Visual cycle modulator / Retinoid analog

This page covers all Visual cycle modulator / Retinoid analog drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Visual cycle (retinoid metabolism pathway).

Targets

Visual cycle (retinoid metabolism pathway)

Marketed (1)

• PA · Fovea Pharmaceuticals SA · Ophthalmology
  PA is a prodrug that is converted to its active form to modulate retinal function and treat vision disorders.

Phase 3 pipeline (1)

• ALK-001 oral capsule · Alkeus Pharmaceuticals, Inc. · Ophthalmology
  ALK-001 is a retinoid that reduces toxic bisretinoid accumulation in the retina by inhibiting the visual cycle.

Patent intelligence

• visual cycle modulator patent landscape — aggregated cliff calendar, attackable patents, originator estates